Comparison Chart Matinas BioPharma Holdings, Inc.
Stocks
MTNB
US5768104029
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:10:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.510 USD | -20.53% |
|
-11.21% | -82.82% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Bio Therapeutic Drugs | -20.53% | -11.21% | -82.82% | -92.71% | -99.82% | 1.48M |  | | |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma Holdings, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
